- Laparoscopic surgery for early ovarian cancer
-
Aoki D
- KMID: 2130094
- J Gynecol Oncol.
- 2014 Jul;25(3):168-169.
- doi: 10.3802/jgo.2014.25.3.168
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- The 5th Biennial Meeting of the Asian Society of Gynecologic Oncology, November 30th to December 2nd, 2017
-
Tominaga E, Kobayashi , Aoki D
- KMID: 2404023
- J Gynecol Oncol.
- 2018 Mar;29(2):e33.
- doi: 10.3802/jgo.2018.29.e33
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Current status and future directions of ovarian cancer prognostic models
-
Kobayashi Y, Banno K, Aoki D
- KMID: 2526380
- J Gynecol Oncol.
- 2021 Mar;32(2):e34.
- doi: 10.3802/jgo.2021.32.e34
-
- CITED
-
- Close
- SHARE
-
- Close
- Management of ovarian cancer patients in affected areas during COVID-19 pandemic: Japan and Korea
-
Kobayashi , Suh DH, Aoki D, Kim JW
- KMID: 2500490
- J Gynecol Oncol.
- 2020 Apr;31(3):e65.
- doi: 10.3802/jgo.2020.31.e65
-
- CITED
-
- Close
- SHARE
-
- Close
- Erratum: Author Correction. Management of ovarian cancer patients in affected areas during COVID-19 pandemic: Japan and Korea
-
Kobayashi Y, Suh DH, Tsuji K, Kim JY, Shin S, Aoki D, Kim JW
- KMID: 2511994
- J Gynecol Oncol.
- 2020 Sep;31(5):e87.
- doi: 10.3802/jgo.2020.31.e87
-
- CITED
-
- Close
- SHARE
-
- Close
- The first-round results of a populationbased cohort study of HPV testing in Japanese cervical cancer screening: baseline characteristics, screening results, and referral rate
-
Kono K, Morisada T, Saika K, Aoki ES, Miyagi E, Ito K, Takahashi H, Nakayama T, Saito H, Aoki D
- KMID: 2526389
- J Gynecol Oncol.
- 2021 May;32(3):e29.
- doi: 10.3802/jgo.2021.32.e29
Objective: In 2013, a cohort study aimed to clarify the positive and negative effects of introducing the human papillomavirus (HPV) testing for population-based cervical cancer screening has been launched in... -
- CITED
-
- Close
- SHARE
-
- Close
- Current state and outlook for drug repositioning anticipated in the field of ovarian cancer
-
Kobayashi , Banno K, Kunitomi H, Tominaga E, Aoki D
- KMID: 2429579
- J Gynecol Oncol.
- 2019 Jan;30(1):e10.
- doi: 10.3802/jgo.2019.30.e10
Ovarian cancer is the seventh most common cancer and the eighth most common cause of cancer mortality in women. Although standard chemotherapy is the established treatment for ovarian cancer, the... -
- CITED
-
- Close
- SHARE
-
- Close
- Tumor volume and lymphovascular space invasion as a prognostic factor in early invasive adenocarcinoma of the cervix
-
Murakami I, Fujii T, Kameyama K, Iwata T, Saito M, Kubushiro , Aoki D
- KMID: 2245173
- J Gynecol Oncol.
- 2012 Jul;23(3):153-158.
- doi: 10.3802/jgo.2012.23.3.153
OBJECTIVE: The aim of this study was to investigate the risk and recurrence of early invasive adenocarcinoma of the cervix, and to determine whether non-radical methods of management could be... -
- CITED
-
- Close
- SHARE
-
- Close
- p16INK4a immunohistochemistry is a promising biomarker to predict the outcome of low grade cervical intraepithelial neoplasia: comparison study with HPV genotyping
-
Nishio S, Fujii T, Nishio H, Kameyama K, Saito M, Iwata T, Kubushiro , Aoki D
- KMID: 2288527
- J Gynecol Oncol.
- 2013 Jul;24(3):215-221.
- doi: 10.3802/jgo.2013.24.3.215
OBJECTIVE: In cervical intraepithelial neoplasia (CIN), p16INK4a immunohistochemistry has been reported to be a useful diagnostic biomarker. However, limited information is available about the association between the p16INK4a immunohistochemistry and... -
- CITED
-
- Close
- SHARE
-
- Close
- Screening for Lynch syndrome using risk assessment criteria in patients with ovarian cancer
-
Takeda T, Tsuji K, Banno K, Yanokura M, Kobayashi , Tominaga E, Aoki D
- KMID: 2409933
- J Gynecol Oncol.
- 2018 May;29(3):e29.
- doi: 10.3802/jgo.2018.29.e29
OBJECTIVE: Lynch syndrome is a cancer predisposition syndrome caused by germline mutation of DNA mismatch repair (MMR) genes. Lynch syndrome only causes about 0.4% of cases of ovarian cancer, which... -
- CITED
-
- Close
- SHARE
-
- Close
- LAMC1 is a prognostic factor and a potential therapeutic target in endometrial cancer
-
Kunitomi H, Kobayashi , Wu RC, Takeda T, Tominaga E, Banno K, Aoki D
- KMID: 2470864
- J Gynecol Oncol.
- 2020 Mar;31(2):e11.
- doi: 10.3802/jgo.2020.31.e11
OBJECTIVE: With the emerging significance of genetic profiles in the management of endometrial cancer, the identification of tumor-driving genes with prognostic value is a pressing need. The LAMC1 gene, encoding... -
- CITED
-
- Close
- SHARE
-
- Close
- Development of a prognostic prediction support system for cervical intraepithelial neoplasia using artificial intelligence-based diagnosis
-
Takahashi T, Matsuoka H, Sakurai R, Akatsuka J, Kobayashi Y, Nakamura M, Iwata T, Banno K, Matsuzaki M, Takayama J, Aoki D, Yamamoto Y, Tamiya G
- KMID: 2537905
- J Gynecol Oncol.
- 2022 Sep;33(5):e57.
- doi: 10.3802/jgo.2022.33.e57
Objective Human papillomavirus subtypes are predictive indicators of cervical intraepithelial neoplasia (CIN) progression. While colposcopy is also an essential part of cervical cancer prevention, its accuracy and reproducibility are limited because... -
- CITED
-
- Close
- SHARE
-
- Close
- Prognostication of early-onset endometrioid endometrial cancer based on genome-wide DNA methylation profiles
-
Hirano T, Arai E, Fujimoto M, Nakayama Y, Tian Y, Ito N, Makabe T, Yamagami W, Susumu N, Aoki D, Kanai Y
- KMID: 2537965
- J Gynecol Oncol.
- 2022 Nov;33(6):e74.
- doi: 10.3802/jgo.2022.33.e74
Objective The aim of this study was to establish criteria that would indicate whether fertility preservation therapy would likely be safe for patients aged 40 years or less with endometrioid endometrial... -
- CITED
-
- Close
- SHARE
-
- Close
- Lymphadenectomy for primary ovarian cancer: a systematic review and meta-analysis
-
Chiyoda T, Sakurai M, Satoh T, Nagase S, Mikami M, Katabuchi H, Aoki D
- KMID: 2511979
- J Gynecol Oncol.
- 2020 Sep;31(5):e67.
- doi: 10.3802/jgo.2020.31.e67
Objective: To assess the effectiveness of lymphadenectomy at primary debulking surgery (PDS) on the survival of patients with epithelial ovarian cancer (EOC). Methods: We searched PubMed, Ichushi, and the Cochrane Library.... -
- CITED
-
- Close
- SHARE
-
- Close
- Is repeated high-dose medroxyprogesterone acetate (MPA) therapy permissible for patients with early stage endometrial cancer or atypical endometrial hyperplasia who desire preserving fertility?
-
Yamagami W, Susumu N, Makabe T, Sakai K, Nomura H, Kataoka F, Hirasawa A, Banno K, Aoki D
- KMID: 2404016
- J Gynecol Oncol.
- 2018 Mar;29(2):e21.
- doi: 10.3802/jgo.2018.29.e21
OBJECTIVE: Reports on the repeated administration of medroxyprogesterone acetate (MPA) for intrauterine recurrence after fertility-preserving therapy for atypical endometrial hyperplasia (AEH) and early grade 1 endometrioid carcinoma (G1) are lacking.... -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of lymphadenectomy on the treatment of endometrial cancer using data from the JSOG cancer registry
-
Saotome K, Yamagami W, Machida H, Ebina Y, Kobayashi Y, Tabata T, Kaneuchi M, Nagase S, Enomoto T, Aoki D, Mikami M
- KMID: 2511568
- Obstet Gynecol Sci.
- 2021 Jan;64(1):80-89.
- doi: 10.5468/ogs.20186
Objective Regional lymph node (LN) dissection is a standard surgical procedure for endometrial cancer, but there is currently no clear consensus on its therapeutic significance. We aimed to determine the... -
- CITED
-
- Close
- SHARE
-
- Close
- The trend and outcome of postsurgical therapy for high-risk early-stage cervical cancer with lymph node metastasis in Japan: a report from the Japan Society of Gynecologic Oncology (JSGO) guidelines evaluation committee
-
Ikeda M, Shida M, Shigeta S, Nagase S, Takahashi F, Yamagami W, Katabuchi H, Yaegashi N, Aoki D, Mikami M
- KMID: 2526401
- J Gynecol Oncol.
- 2021 May;32(3):e44.
- doi: 10.3802/jgo.2021.32.e44
Objective: The Japan Society of Gynecologic Oncology published the first guidelines for the treatment of cervical cancer in 2007. The aim of this research was to evaluate the influence of... -
- CITED
-
- Close
- SHARE
-
- Close
- TP53 variants in p53 signatures and the clonality of STICs in RRSO samples
-
Akahane T, Masuda K, Hirasawa A, Kobayashi Y, Ueki A, Kawaida M, Misu K, Nakamura K, Nagai S, Chiyoda T, Yamagami W, Hayashi S, Kataoka F, Banno K, Sugano K, Okita H, Kosaki K, Nishihara H, Aoki D
- KMID: 2537895
- J Gynecol Oncol.
- 2022 Jul;33(4):e50.
- doi: 10.3802/jgo.2022.33.e50
Objective Precursor lesions may be identified in fallopian tube tissue after risk-reducing salpingo-oophorectomy (RRSO) in patients with pathogenic variants of BRCA1/2. Serous tubal intraepithelial carcinoma (STIC) is considered a precursor of... -
- CITED
-
- Close
- SHARE
-
- Close
- Japan Society of Gynecologic Oncology 2018 guidelines for treatment of uterine body neoplasms
-
Yamagami W, Mikami M, Nagase S, Tabata T, Kobayashi Y, Kaneuchi M, Kobayashi H, Yamada H, Hasegawa K, Fujiwara H, Katabuchi H, Aoki D
- KMID: 2465192
- J Gynecol Oncol.
- 2020 Jan;31(1):e18.
- doi: 10.3802/jgo.2020.31.e18
The Fourth Edition of the Guidelines for Treatment of Uterine Body Neoplasm was published in 2018. These guidelines include 9 chapters: 1. Overview of the guidelines, 2. Initial treatment for... -
- CITED
-
- Close
- SHARE
-
- Close
- The 2020 Japan Society of Gynecologic Oncology guidelines for the treatment of ovarian cancer, fallopian tube cancer, and primary peritoneal cancer
-
Tokunaga H, Mikami M, Nagase S, Kobayashi Y, Tabata T, Kaneuchi M, Satoh T, Hirashima Y, Matsumura N, Yokoyama Y, Kawana K, Kyo S, Aoki D, Katabuchi H
- KMID: 2526387
- J Gynecol Oncol.
- 2021 Mar;32(2):e49.
- doi: 10.3802/jgo.2021.32.e49
The fifth edition of the Japan Society of Gynecologic Oncology guidelines for the treatment of ovarian cancer, fallopian tube cancer, and primary peritoneal cancer was published in 2020. The guidelines... -
- CITED
-
- Close
- SHARE
-
- Close
